An integrated view on the luteal phase: Diagnosis and treatment in subfertility

Clinical Endocrinology

Volumn 77, Issue 4, 2012, Pages 500-507

  Sonntag, Barbara ^a   Ludwig, Michael ^a  

^a Zentrum fur Endokrinologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; GONADOTROPIN; INHIBIN B; INTERLEUKIN 1BETA; LUTEINIZING HORMONE; PROGESTERONE; TUMOR NECROSIS FACTOR ALPHA;

ANOVULATION; ARTICLE; CORPUS LUTEUM FUNCTION; DIAGNOSTIC PROCEDURE; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; HORMONAL THERAPY; INFORMATION RETRIEVAL; INVOLUTION; LUTEAL PHASE; LUTEOLYSIS; MEDLINE; MENSTRUAL IRREGULARITY; NIDATION; OOCYTE DEVELOPMENT; OVARY FOLLICLE DEVELOPMENT; OVULATION; PREGNANCY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROPHYLAXIS; SPONTANEOUS ABORTION; TREATMENT INDICATION;

ALGORITHMS; CORPUS LUTEUM; FEMALE; FOLLICULAR PHASE; HUMANS; INFERTILITY; LUTEAL PHASE; PROGESTERONE;

EID: 84867285807     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04464.x     Document Type: Article

References (61)

1. Devoto, L., Kohen, P., Vega, M. et al. (2002) Control of human luteal steroidogenesis. Molecular and Cellular Endocrinology 186, 137-141.
2. Richter, K.S., Bugge, K.R., Bromer, J.G. et al. (2007) Relationship between endometrial thickness and embryo implantation, based on 1,294 cycles of in vitro fertilization with transfer of two blastocyst- stage embryos. Fertility and Sterility 87, 53-59.
3. Bromer, J.G., Aldad, T.S. & Taylor, H.S. (2009) Defining the proliferative phase endometrial defect. Fertility and Sterility 91, 698-704.
4. Strowitzki, T., Germeyer, A., Popovici, R. et al. (2006) The human endometrium as a fertility-determining factor. Hum Reprod Update 12, 617-630.
5. Wilcox, A.J., Baird, D.D. & Weinberg, C.R. (1999) Time of implantation of the conceptus and loss of pregnancy. New England Journal of Medicine 340, 1796-1799.
6. Csapo, A.I. & Pulkkinen, M. (1978) Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence. Obstetrical & Gynecological Survey 33, 69-81.
7. Csapo, A.I., Pulkkinen, M.O., Ruttner, B. et al. (1972) The significance of the human corpus luteum in pregnancy maintenance. I. Preliminary studies. American Journal of Obstetrics and Gynecology 112, 1061-1067.
8. Jarvela, I.Y., Ruokonen, A. & Tekay, A. (2008) Effect of rising hCG levels on the human corpus luteum during early pregnancy. Human Reproduction 23, 2775-2781.
9. Gilchrist, R.B., Lane, M. & Thompson, J.G. (2008) Oocytesecreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update 14, 159-177.
10. Russell, D.L. & Robker, R.L. (2007) Molecular mechanisms of ovulation: co-ordination through the cumulus complex. Human Reproduction Update 13, 289-312.
11. Baerwald, A.R., Adams, G.P. & Pierson, R.A. (2012) Ovarian antral folliculogenesis during the human menstrual cycle: a review. Human Reproduction Update 18, 73-91.
12. Knight, P.G. & Glister, C. (2006) TGF-beta superfamily members and ovarian follicle development. Reproduction 132, 191-206.
13. Verberg, M.F.G., Eijkemans, M.J.C., Macklon, N.S. et al. (2009) The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis. Human Reproduction Update 15, 5-12.
14. Devoto, L., Fuentes, A., Kohen, P. et al. (2009) The human corpus luteum: life cycle and function in natural cycles. Fertility and Sterility 92, 1067-1079.
15. Niswender, G.D., Juengel, J.L., Silva, P.J. et al. (2000) Mechanisms controlling the function and life span of the corpus luteum. Physiological Reviews 80, 1-29.
16. Mais, V., Keyser, R.R., Cetel, N.S. et al. (1986) The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropinreleasing hormone antagonist as a probe. Journal of Clinical Endocrinology & Metabolism 62, 1250-1255.
17. Duffy, D.M., Stewart, D.R. & Stouffer, R.L. (1999) Titrating luteinizing hormone replacement to sustain the structure and function of the corpus luteum after gonadotropin-releasing hormone antagonist treatment in rhesus monkeys. Journal of Clinical Endocrinology and Metabolism 84, 342-349.
18. Bishop, C.V., Bogan, R.L., Hennebold, J.D. et al. (2011) Analysis of microarray data from the macaque corpus luteum; the search for common themes in primate luteal regression. Molecular Human Reproduction 17, 143-151.
19. Jones, G.E. (1949) Some newer aspects of the management of infertility. Journal of the American Medical Association 141, 1123-1129.
20. Crosignani, P.G. & Rubin, B.L. (2000) Optimal use of infertility diagnostic tests and treatments. The ESHRE Capri Workshop Group. Human Reproduction 15, 723-732.
21. Ellinwood, W.E., Norman, R.L. & Spies, H.G. (1984) Changing frequency of pulsatile luteinizing hormone and progesterone secretion during the luteal phase of the menstrual cycle of rhesus monkeys. Biology of Reproduction 31, 714-722.
22. Jordan, J., Craig, K., Clifton, D.K. et al. (1994) Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertility and Sterility 62, 54-62.
23. Noyes, R.W., Hertig, A.T. & Rock, J. (1950) Dating the endometrial biopsy. Fertility and Sterility 1, 3-9.
24. Murray, M.J., Meyer, W.R., Zaino, R.J. et al. (2004) A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women. Fertility and Sterility 81, 1333-1343.
25. Coutifaris, C., Myers, E.R., Guzick, D.S. et al. (2004) Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertility and Sterility 82, 1264-1272.
26. Usadi, R.S., Groll, J.M., Lessey, B.A. et al. (2008) Endometrial development and function in experimentally induced luteal phase deficiency. Journal of Clinical Endocrinology and Metabolism 93, 4058-4064.
27. Altmae, S., Martinez-Conejero, J.A., Salumets, A. et al. (2010) Endometrial gene expression analysis at the time of embryo implantation in women with unexplained infertility. Molecular Human Reproduction 16, 178-187.
28. Branch, D.W., Gibson, M. & Silver, R.M. (2010) Clinical practice. Recurrent miscarriage. New England Journal of Medicine 363, 1740-1747.
29. Petra, D.S. (2006) Rational diagnosis and treatment in infertility. Best Practice & Research Clinical Obstetrics & Gynaecology 20, 647-664.
30. Lockwood, C.J. (2011) Mechanisms of normal and abnormal endometrial bleeding. Menopause 18, 408-411.
31. Malcolm, C.E. & Cumming, D.C. (2003) Does anovulation exist in eumenorrheic women? Obstetrics and Gynecology 102, 317-318.
32. Gemzell-Danielsson, K., Schellschmidt, I. & Apter, D. (2012) A randomized, phase, II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertility and Sterility 97, 616-622.
33. Zegers-Hochschild, F., Gomez Lira C., Parada, M. et al. (1984) A comparative study of the follicular growth profile in conception and nonconception cycles. Fertility and Sterility 41, 244-247.
34. Ireland, J.J., Zielak-Steciwko, A.E., Jimenez-Krassel, F. et al. (2009) Variation in the ovarian reserve is linked to alterations in intrafollicular estradiol production and ovarian biomarkers of follicular differentiation and oocyte quality in cattle. Biology of Reproduction 80, 954-964.
35. Davis, O.K., Berkeley, A.S., Naus, G.J. et al. (1989) The incidence of luteal phase defect in normal, fertile women, determined by serial endometrial biopsies. Fertility and Sterility 51, 582-586.
36. Brown, J.B. (2011) Types of ovarian activity in women and their significance: the continuum (a reinterpretation of early findings). Hum Reprod Update 17, 141-158.
37. Soules, M.R., Clifton, D.K., Cohen, N.L. et al. (1989) Luteal phase deficiency: abnormal gonadotropin and progesterone secretion patterns. Journal of Clinical Endocrinology and Metabolism 69, 813-820.
38. De Souza, M.J., Toombs, R.J., Scheid, J.L. et al. (2010) High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures. Human Reproduction 25, 491-503.
39. Nawroth, F. & Ludwig, M. (2008) What can we expect if we measure hormones in eumenorrhoeic infertile patients? Reproductive BioMedicine Online 16, 621-626.
40. Hatasaka, H. (2011) New perspectives for unexplained infertility. Clinical Obstetrics and Gynecology 54, 727-733.
41. Qublan, H., Amarin, Z., Nawasreh, M. et al. (2006) Luteinized unruptured follicle syndrome: incidence and recurrence rate in infertile women with unexplained infertility undergoing intrauterine insemination. Human Reproduction 21, 2110-2113.
42. Coetsier, T. & Dhont, M. (1996) Complete and partial luteinized unruptured follicle syndrome after ovarian stimulation with clomiphene citrate/human menopausal gonadotrophin/human chorionic gonadotrophin. Human Reproduction 11, 583-587.
43. Fan, H.Y., Liu, Z., Shimada, M. et al. (2009) MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility. Science 324, 938-941.
44. White, R., Leonardsson, G., Rosewell, I. et al. (2000) The nuclear receptor co-repressor nrip1 (RIP140) is essential for female fertility. Nature Medicine 6, 1368-1374.
45. Kamath, M. & George, K. (2011) Letrozole or clomiphene citrate as first line for anovulatory infertility: a debate. Reproductive Biology and Endocrinology 9, 86.
46. Verhulst, S.M., Cohlen, B.J., Hughes, E. et al. (2006) Intra-uterine insemination for unexplained subfertility. Cochrane Database Systematic Review 4, CD001838.
47. Reindollar, R.H., Regan, M.M., Neumann, P.J. et al. (2010) A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertility and Sterility 94, 888-899.
48. Devoto, L., Kohen, P., Munoz, A. et al. (2009) Human corpus luteum physiology and the luteal-phase dysfunction associated with ovarian stimulation. Reprod Biomed Online 18 (Suppl 2), 19-24.
49. Fauser, B.C. & Devroey, P. (2003) Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends in Endocrinology and Metabolism 14, 236-242.
50. Van Der Linden, M., Buckingham, K., Farquhar, C. et al. (2011) Luteal phase support for assisted reproduction cycles. Cochrane Database Systematic Review 10, CD009154.
51. Griesinger, G. (2011) Editorial commentary: is it time to abandon progesterone supplementation of early pregnancy after IVF? Human Reproduction 26, 1017-1019.
52. Erdem, A., Erdem, M., Atmaca, S. et al. (2009) Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study. Fertility and Sterility 91, 2508-2513.
53. Proctor, A., Hurst, B.S., Marshburn, P.B. et al. (2006) Effect of progesterone supplementation in early pregnancy on the pregnancy outcome after in vitro fertilization. Fertility and Sterility 85, 1550-1552.
54. Li, T.C., Spuijbroek, M.D.E.H., Tuckerman, E. et al. (2000) Endocrinological and endometrial factors in recurrent miscarriage. BJOG: An International Journal of Obstetrics & Gynaecology 107, 1471-1479.
55. Prakash, A., Li, T.C., Laird, S. et al. (2006) Absence of follicular phase defect in women with recurrent miscarriage. Fertility and Sterility 85, 1784-1790.
56. Jauniaux, E., Farquharson, R.G., Christiansen, O.B. et al. (2006) Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Human Reproduction 21, 2216-2222.
57. Haas, D.M. & Ramsey, P.S. (2008) Progestogen for preventing miscarriage. Cochrane Database Systematic Review 2, CD003511.
58. Devaseelan, P., Fogarty, P.P. & Regan, L. (2010) Human chorionic gonadotrophin for threatened miscarriage. Cochrane Database Systematic Review 5, CD007422.
59. Szekeres-Bartho, J. & Balasch, J. (2008) Progestagen therapy for recurrent miscarriage. Hum Reprod Update 14, 27-35.
60. Saravelos, S.H. & Li, T.-C. (2012) Unexplained recurrent miscarriage: how can we explain it? Human Reproduction 27, 1882 -1886.
61. Wahabi, H.A., Abed Althagafi, N.F., Elawad, M. et al. (2011) Progestogen for treating threatened miscarriage. Cochrane Database Systematic Review 12, CD005943.